CTI adds CAD to PET/CT

Article

Computer-aided detection, initially restricted to mammography, is entering the functional imaging arena. CTI Molecular Imaging is showcasing CAD technology during the RSNA meeting on its Reveal PET/CT scanners, as well as the Reveal MVS PET/CT workstation. Under a recently inked exclusive agreement with R2 Technology, CTI has begun offering the first commercially available CAD system for multidetector CT examinations of the chest.

 

Computer-aided detection, initially restricted to mammography, is entering the functional imaging arena. CTI Molecular Imaging is showcasing CAD technology during the RSNA meeting on its Reveal PET/CT scanners, as well as the Reveal MVS PET/CT workstation. Under a recently inked exclusive agreement with R2 Technology, CTI has begun offering the first commercially available CAD system for multidetector CT examinations of the chest.

The Reveal PET/CT system merges PET and CT technologies to generate functional and anatomical data in a single scan, which improves the localization of metabolic hot spots for cancer staging.

FDG, the active metabolite of PET scanning, accumulates not only in disease sites, but also in areas of inflammation and infection. The addition of CAD to the Reveal PET/CT system helps decipher inflammatory isotope uptake from metabolic localization of true malignant pathology so infection or inflammation in the pleural lining will not be mistaken for lung cancer.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
Leading Breast Radiologists Discuss Rise of Breast Cancer Incidence in Women Under 40
Diagnostic Imaging’s Weekly Scan: August 31 — September 6
Emerging Trends in Breast Imaging: An Interview with Zeeshan Shah, MD
© 2025 MJH Life Sciences

All rights reserved.